摘要
Objective To evaluate the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in young patients with high-risk multiple myeloma(HRMM)and analyze the factors affecting patient prognosis.Methods In this retrospective study,we analyzed the clinical data of 14 patients with HRMM with cytogenetic abnormalities or high-risk biological factors who underwent allo-HSCT at the Hematopoietic Stem Cell Transplantation Center of the Institute of Hematology&Blood Diseases Hospital between November 2016 and November 2022.
作者
潘攀
PAN Pan(State Key Lab,Experiment Hematol,Natl Clin Blood Dis Res Center,Haihe Cell Ecosys Lab,Insit Hematol&Blood Dis Hosp,PUMC&CAMS,Tianjin 300020)
